Zymeworks, Inc. (ZYME)
22.71
-0.46
(-1.99%)
USD |
NASDAQ |
Feb 13, 14:13
Zymeworks Cash from Investing (Quarterly) : 0.31M for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Jazz Pharmaceuticals Plc | -327.80M |
| Johnson & Johnson | -4.485B |
| Regeneron Pharmaceuticals, Inc. | 220.30M |
| Vertex Pharmaceuticals, Inc. | -117.00M |
| CorMedix, Inc. | -291.32M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -31.92M |
| Cash from Financing (Quarterly) | -2.497M |
| Free Cash Flow | -64.45M |
| Free Cash Flow Per Share (Quarterly) | -0.4267 |
| Free Cash Flow to Equity (Quarterly) | -32.55M |
| Free Cash Flow to Firm (Quarterly) | -32.33M |
| Free Cash Flow Yield | -3.75% |